Computer Guided Single Needle Arthrocentesis
1 other identifier
interventional
24
1 country
1
Brief Summary
The intra-articular injection is considered the first line of minimally invasive treatment in temporomandibular joint with internal derangement (TMJ-ID) patients who do not respond to conservative treatment. The single-needle technique arthrocentesis has emerged to add reliability, convenience, ease the performance of the procedure, and eliminate the need for multiple punctures the Aim of this study is to assess clinical applicability and therapeutic outcomes of computer guided single needle arthrocentesis with platelet rich plasma using Shepard's cannula, in comparison with conventional free-hand technique, in the management of disc displacement with reduction of the TMJ.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2025
CompletedFirst Submitted
Initial submission to the registry
December 13, 2025
CompletedFirst Posted
Study publicly available on registry
December 29, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedDecember 29, 2025
December 1, 2025
8 months
December 13, 2025
December 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
objective assessment of joint function and mandibular excursion
Clinical evaluation will be based on the Helkimo's clinical dysfunction index (Di), which is a part of the Helkimo index that provides an objective assesment of joint function and mandibular excursion. All patients will be assessed immediately post-operative, 1 and 3 months. Postoperative clinical evaluation values will be compared to the preoperative baseline preoperative values.
3 months
Secondary Outcomes (1)
Duration of the Operation
intraoperative
Study Arms (2)
Patients with TMJ ID + reduction managed with computer-guided single needle arthrocentesis
EXPERIMENTALPatients with TMJ ID + reduction managed with computer-guided single needle arthrocentesis in adjunct to PRP intra-articular injection.
Patients with TMJ ID + reduction managed with conventional free hand single needle arthrocentesis
PLACEBO COMPARATORPatients with TMJ ID + reduction managed with conventional free hand single needle arthrocentesis in adjunct to PRP intra-articular injection
Interventions
Patients with TMJ ID + reduction managed with conventional free hand single needle arthrocentesis in adjunct to PRP intra-articular injection.
Patients with TMJ ID + reduction managed with computer-guided single needle arthrocentesis in adjunct to PRP intra-articular injection
Eligibility Criteria
You may qualify if:
- Patients diagnosed with internal derangement according to Wilkes stage I and II.
- Adult patients above 18 years old.
- Patients who would not respond to conservative treatment as a first line of treatment
You may not qualify if:
- Patients with Wilkes stage III, IV, V.
- Patients suffering from any systemic diseases, platelets function disorders, fibrinogen deficiency.
- History of mandibular fracture.
- Lactating, pregnant or planning pregnancy women.
- Patients receiving anticoagulation treatment or NSAIDS within 48 hours preoperatively, corticosteroid injection at treatment site within 1 month or systemic use of corticosteroids within 2 weeks.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Outpatient clinics of Faculty of Dentistry, Alexandria University, Egypt Alexandria
Alexandria, Alexandria Governorate, 21523, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
yehia El-Mahallawy, Phd
Faculty of Dentistry, Alexandria University, Alexandria, Alexandria
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Sequentially numbered, opaque, sealed envelopes (SNOSE) allocation concealment method will be utilized. Each participant included in the study will be given a serial number that will be used in the allocation. These numbers will be written in identical sheets of paper with the group to which each participant is allocated and placed inside opaque envelopes carrying the respective names of participants. A trial independent personnel will be assigned the role of keeping the envelopes and unfolding them only at the time of the operation, so that the participant is allocated to a group which is concealed from the operator
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 13, 2025
First Posted
December 29, 2025
Study Start
April 1, 2025
Primary Completion
November 30, 2025
Study Completion
March 1, 2026
Last Updated
December 29, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
all data will be de-identified to protect the participant data. patients signed an informed consent for the use of their medical records and data for study